Refoxy Pharmaceuticals
GermanyWho owns Refoxy Pharmaceuticals?
Refoxy Pharmaceuticals is a German Biotech company, currently owned by Boehringer Ingelheim Venture Fund since 2024 and Apollo Health Ventures.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods · co-invest detected
More from Apollo Health Ventures Fund I
Other portfolio companies in the same fund.
US
UKMore Apollo Health Ventures portfolio companies
From the same investor, across funds.
France
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Refoxy Pharmaceuticals?
Refoxy Pharmaceuticals is currently owned by Boehringer Ingelheim Venture Fund and Apollo Health Ventures, through Apollo Health Ventures Fund I, since 2024.
When did Boehringer Ingelheim Venture Fund and 1 other acquire Refoxy Pharmaceuticals?
Boehringer Ingelheim Venture Fund and 1 other acquired Refoxy Pharmaceuticals in 2024.
Who has owned Refoxy Pharmaceuticals over time?
Refoxy Pharmaceuticals has been through 2 private-equity ownership periods: Apollo Health Ventures · via Apollo Health Ventures Fund I · since 2020; Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2024.